Status:
RECRUITING
Combined Effects of Alternate Nostril Breathing and Aerobic Interval Training on Blood Pressure and Heart Rate Products in Patients With Hypertension
Lead Sponsor:
Foundation University Islamabad
Conditions:
Hypertension (HTN)
Eligibility:
All Genders
25-50 years
Phase:
NA
Brief Summary
Hypertension (HTN) is the foremost preventable risk factor for cardiovascular disease (CVD) and all-cause mortality, contributing to over 7 million deaths annually within the nearly 17 million attribu...
Eligibility Criteria
Inclusion
- Adults aged 25- 50 years -males and females
- Patients diagnosed with stage 1 hypertension 130 - 139 / 80 - 89 mmHg and stage 2 hypertension, BP level ≥140/90 mmHg. according to AHA/ACC 2017 Guidelines-Individuals who are able to understand and follow the instructions for exercise
Exclusion
- Diagnosed with any current infections
- subjects with diagnosed musculoskeletal or neurological conditions which hinder participation in physical activity program
- Active Smokers
- Those with any contraindication to exercise testing or training.
- Pregnant females
Key Trial Info
Start Date :
January 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 15 2026
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT07177989
Start Date
January 15 2025
End Date
February 15 2026
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Foundation University College of Physical Therapy, Islamabad, 44000
Rawalpindi, Pakistan, 46000